MedTrace Logo

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

NCT04812327 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-08-11

No results posted yet for this study

Summary

This study is being conducted to assess the performance of the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2, used in serial testing, in identification of infectious, asymptomatic individuals. This information may be used to inform development of an effective testing strategy by policy makers.

Conditions

  • Covid19
  • SARS CoV-2

Interventions

DIAGNOSTIC_TEST

BD Veritor Plus System for Rapid Detection of SARS CoV-2

Nasal Sawb for the conduct of the Veritor Antigen Test

DIAGNOSTIC_TEST

rt-PCR

Nasopharyngeal Swab for the conduct of a rt-PCR

DIAGNOSTIC_TEST

viral culture

Nasopharyngeal Swab for the conduct of viral culture

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Principal Investigators

  • Yen Seow Tan, MD · Hospital Employee

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2021-09-30
Completion
2021-11-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812327 on ClinicalTrials.gov